http://www.mmm-online.com/generic-drugs/topic/22300/ Articles tagged with Generic Drugs from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no For a country bent on healthcare cost control, findings represent an opportunity: authors say nearly 8% of the nation's total outlay could have been avoided. http://www.mmm-online.com/researchers-spot-213b-of-wasteful-drug-spending/article/299081/ Wed, 19 Jun 2013 13:00:00 GMT For a country bent on healthcare cost control, findings represent an opportunity: authors say nearly 8% of the nation's total outlay could have been avoided. MMM The Supreme Court split the baby on "pay-for-delay" settlements, allowing them to continue but opening manufacturers that make them up to lawsuits. http://www.mmm-online.com/pay-for-delay-deals-can-go-on-court-rules-but-not-without-legal-risk/article/299089/ Mon, 17 Jun 2013 19:52:50 GMT The Supreme Court split the baby on "pay-for-delay" settlements, allowing them to continue but opening manufacturers that make them up to lawsuits. MMM Good and bad news about Pradaxa; Plan B decision not deemed a big threat to Teva's sales; Study says Medicare patients more likely to receive brand-name medications than VA patients http://www.mmm-online.com/business-briefs-boehringer-ingelheim-teva-medicare/article/298497/ Wed, 12 Jun 2013 17:03:59 GMT Good and bad news about Pradaxa; Plan B decision not deemed a big threat to Teva's sales; Study says Medicare patients more likely to receive brand-name medications than VA patients MMM The effectiveness of new drugs is in decline, says an analysis, and researchers say comparative studies should look beyond efficacy measures. http://www.mmm-online.com/pill-plus-value-adds-beat-brand-names-in-the-age-of-acos/article/297136/ Mon, 10 Jun 2013 17:08:45 GMT The effectiveness of new drugs is in decline, says an analysis, and researchers say comparative studies should look beyond efficacy measures. MMM AbbVie lays off 100 R&D staff; Teva looks to expand Copaxone footprint; researchers crack HIV protein code; monitors may be misleading diabetics and a prototype sensor turns iPhones into virus hunters. http://www.mmm-online.com/business-briefs-abbvie-teva-hiv-diabetes-iphone/article/295475/ Thu, 30 May 2013 15:59:52 GMT AbbVie lays off 100 R&D staff; Teva looks to expand Copaxone footprint; researchers crack HIV protein code; monitors may be misleading diabetics and a prototype sensor turns iPhones into virus hunters. MMM Amgen and Astellas team up to take on Japan; GSK acquires Swiss vaccine developer's innovative platform; Ireland makes generic switches easier; Novo backs wet AMD therapy; Nike ditches Livestrong http://www.mmm-online.com/business-briefs-amgen-and-astellas-gsk-teva-novo-livestrong/article/295369/ Wed, 29 May 2013 16:33:31 GMT Amgen and Astellas team up to take on Japan; GSK acquires Swiss vaccine developer's innovative platform; Ireland makes generic switches easier; Novo backs wet AMD therapy; Nike ditches Livestrong MMM Pfizer cuts 136 workers loose in Ireland, BMS is investing in heart failure treatments, CMS has an official new leader, and Sanofi's iBGStar may have a competitor. http://www.mmm-online.com/business-briefs-pfizer-bms-cms-sanofi/article/293671/ Thu, 16 May 2013 16:50:50 GMT Pfizer cuts 136 workers loose in Ireland, BMS is investing in heart failure treatments, CMS has an official new leader, and Sanofi's iBGStar may have a competitor. MMM Jolie takes on cancer awareness role, researchers identify another adherence gap, Sanofi gets slapped for scare tactics, Teva may compete for Adcock, AbbVie R&D chief leaves http://www.mmm-online.com/business-briefs-angelina-jolie-adherence-sanofi-teva-abbvie/article/293341/ Tue, 14 May 2013 18:54:50 GMT Jolie takes on cancer awareness role, researchers identify another adherence gap, Sanofi gets slapped for scare tactics, Teva may compete for Adcock, AbbVie R&D chief leaves MMM Two studies released show that the story behind lower consumer healthspend isn't about generics improving health. http://www.mmm-online.com/studies-show-cheaper-drugs-dont-add-up-to-greater-use/article/292626/ Thu, 09 May 2013 16:09:46 GMT Two studies released show that the story behind lower consumer healthspend isn't about generics improving health. MMM GSK and Astellas kick off the race for a new anemia treatment; Orexigen's CEO joins PhRMA; BMS and Merck team up in a hep.-C clinical trial; Novartis lands glaucoma approval; Ireland starts naming preferred drugs; Novo has new New Jersey digs; Vertex releases promising data for new cystic fibrosis treatment. http://www.mmm-online.com/business-briefs-gsk-astellas-vertex-and-orexigen/article/289879/ Mon, 22 Apr 2013 16:19:10 GMT GSK and Astellas kick off the race for a new anemia treatment; Orexigen's CEO joins PhRMA; BMS and Merck team up in a hep.-C clinical trial; Novartis lands glaucoma approval; Ireland starts naming preferred drugs; Novo has new New Jersey digs; Vertex releases promising data for new cystic fibrosis treatment. MMM